View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsNylex (Malaysia) Berhad 과거 순이익 실적과거 기준 점검 0/6Nylex (Malaysia) Berhad은 연평균 23.1%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 연평균 8.8%의 비율로 감소했습니다. 매출은 연평균 66.5%의 비율로 감소했습니다.핵심 정보23.09%순이익 성장률23.18%주당순이익(EPS) 성장률Chemicals 산업 성장률8.86%매출 성장률-66.55%자기자본이익률-11.89%순이익률-874.90%최근 순이익 업데이트29 Feb 2024최근 과거 실적 업데이트Reported Earnings • Oct 04Full year 2022 earnings released: RM0.007 loss per share (vs RM0.004 loss in FY 2021)Full year 2022 results: RM0.007 loss per share (further deteriorated from RM0.004 loss in FY 2021). Net loss: RM1.26m (loss widened 70% from FY 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings.Reported Earnings • Jul 20Full year 2022 earnings released: RM0.28 loss per share (vs RM0.11 profit in FY 2021)Full year 2022 results: RM0.28 loss per share (down from RM0.11 profit in FY 2021). Revenue: RM934.1m (down 19% from FY 2021). Net loss: RM50.4m (down 367% from profit in FY 2021). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 28% per year, which means it is performing significantly worse than earnings.Reported Earnings • Apr 21Third quarter 2022 earnings released: RM0.32 loss per share (vs RM0.028 profit in 3Q 2021)Third quarter 2022 results: RM0.32 loss per share (down from RM0.028 profit in 3Q 2021). Revenue: RM273.8m (down 5.3% from 3Q 2021). Net loss: RM57.7m (down RM62.6m from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.Reported Earnings • Jan 19Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: EPS: RM0.043 (up from RM0.026 in 2Q 2021). Revenue: RM385.4m (up 46% from 2Q 2021). Net income: RM7.73m (up 72% from 2Q 2021). Profit margin: 2.0% (up from 1.7% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 31% per year and the company’s share price has also increased by 31% per year.Reported Earnings • Oct 04Full year 2021 earnings released: EPS RM0.11 (vs RM0.13 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.15b (up 1.4% from FY 2020). Net income: RM18.9m (up RM42.1m from FY 2020). Profit margin: 1.6% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance.Reported Earnings • Jul 31Full year 2021 earnings released: EPS RM0.11 (vs RM0.13 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.15b (up 1.4% from FY 2020). Net income: RM19.3m (up RM42.5m from FY 2020). Profit margin: 1.7% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.모든 업데이트 보기Recent updates공고 • Mar 08Nylex to Delist from Bursa Malaysia on March 11Nylex (Malaysia) Berhad is set to be delisted from Bursa Malaysia on March 11, following the company’s failure to submit its regularisation plan on time. In a filing with Bursa Malaysia on March 6, 2025, the bourse regulator said it has dismissed the company's appeal for a further extension of six months until July 26, 2025 to submit its regularisation plan to the relevant authorities for approval. As such, Bursa Malaysia said the company would be delisted from Bursa Malaysia after two market days from March 6, that is on March 11, 2025. Upon the de-listing of the company, the company will continue to exist but as an unlisted entity. The company can still continue its operations and businesses and proceed with its corporate restructuring.공고 • Sep 27Nylex (Malaysia) Berhad, Annual General Meeting, Oct 29, 2024Nylex (Malaysia) Berhad, Annual General Meeting, Oct 29, 2024, at 09:30 Singapore Standard Time. Location: no. 2a, jalan 13/2, seksyen 13, 46200 petaling jaya, selangor darul ehsan, Malaysia공고 • Jan 31Nylex (Malaysia) Berhad Provides Update Related to Suspension & Delisting of SecuritiesRefer to the Nylex (Malaysia) Berhad’s announcements dated 27 January 2022 and 28 January 2022 in relation to the First Announcement and the announcements made on 16 August 2023, 23 August 2023, 13 October 2023 and 26 January 2024. Unless otherwise stated, all abbreviations and definitions used herein shall have the same meanings as those used in the said announcements. The Board announced that Bursa Securities had via its letter dated 29 January 2024 informed the Company that Bursa Securities has noted that: a) Nylex had failed to submit the proposed regularisation plan to the relevant authorities for approval within the extended timeframe of 26 January 2024 as granted by the Listing Committee via its letter dated 13 October 2023 (“LC Decision Letter”); and b) the Company has on 26 January 2024, appealed/applied for a further extension of time ("Appeal"). In the circumstances and pursuant to paragraph 8.03A(3) of the Listing Requirements and the LC Decision Letter, (i) the trading in the securities of Nylex will be suspended with effect from 7 February 2024 ("Suspension Date") even though the decision on the Appeal is still pending. (ii) However, the de-listing of the securities of the Company upon the expiry of 2 market days from the Suspension Date will be deferred pending the decision on the Appeal by Bursa Securities.New Risk • Jan 30New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RM40.5m (US$8.55m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (RM211k revenue, or US$45k). Market cap is less than US$10m (RM40.5m market cap, or US$8.55m). Minor Risk Share price has been volatile over the past 3 months (11% average weekly change).공고 • Sep 27Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2023Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2023, at 09:30 Singapore Standard Time. Location: No. 2A, Jalan 13/2, Seksyen 13,46200 Petaling Jaya Selangor Malaysia Agenda: To receive the Audited Financial Statements for the financial year ended 31 May 2023 together with the Reports of the Directors and the Auditors; To re-elect as Director, Datin Joanne Marie Lopez who is retiring pursuant to Clause 130 of the Company's Constitution; to approve the payment of Non-Executive Directors' fees for the financial year ended 31 May 2023; to approve the payment of Non-Executive Directors' fees for the financial year ending 31 May 2024, to be paid quarterly in arrears; to re-appoint Messrs BDO PLT as Auditors of the Company and to authorise the Directors to fix their remuneration and to consider other business matters.New Risk • Aug 18New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RM44.9m (US$9.66m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 12% per year over the past 5 years. Revenue is less than US$1m (RM211k revenue, or US$45k). Market cap is less than US$10m (RM44.9m market cap, or US$9.66m).공고 • Jun 29+ 9 more updatesNylex (Malaysia) Berhad Announces Redesignation of Edmond Cheah Swee Leng from Chairman of Nomination and Remuneration Committee to Non Independent and Non Executive Member of Nomination and Remuneration CommitteeNylex (Malaysia) Berhad announced redesignation of EDMOND CHEAH SWEE LENG from Chairman of Nomination and Remuneration Committee to Non Independent and Non Executive Member of Nomination and Remuneration Committee. Age 68, Date of change 28 June 2023. Composition of Nomination and Remuneration Committee(Name and Directorate of members after change). Chairman: Datin Joanne Marie Lopez (Independent Non Executive Director) Members: Datuk Anuar Bin Ahmad (Independent Non Executive Director) Edmond Cheah Swee Leng (Non ndependent Non Executive Director).Board Change • Jan 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 5 highly experienced directors. Independent Non-Executive Director See Yan Lin was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Oct 04Full year 2022 earnings released: RM0.007 loss per share (vs RM0.004 loss in FY 2021)Full year 2022 results: RM0.007 loss per share (further deteriorated from RM0.004 loss in FY 2021). Net loss: RM1.26m (loss widened 70% from FY 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings.공고 • Sep 29Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2022Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2022, at 09:30 Singapore Standard Time. Location: No. 2a, Jalan 13/2, Seksyen 13, 46200 Petaling Jaya Darul Ehsan Selangor Malaysia Agenda: To receive the audited financial statements for the financial year ended 31 May 2022 together with the Reports of the Directors and the Auditors thereon; to re-elect the directors who are retiring by rotation; to approve the payment of Non-Executive Directors' fees for the financial year ended 31 May 2022; to approve the payment of Directors' benefits (excluding Non-Executive Directors' fees) for the Non-Executive Directors from the date of the forthcoming AGM until the next annual general meeting of the Company; to re-appoint Messrs BDO PLT as Auditors of the Company and to authorize the Directors to fix their remuneration; to discuss proposed renewal authority for share buy-back mandate; and to discuss other matters.Reported Earnings • Jul 20Full year 2022 earnings released: RM0.28 loss per share (vs RM0.11 profit in FY 2021)Full year 2022 results: RM0.28 loss per share (down from RM0.11 profit in FY 2021). Revenue: RM934.1m (down 19% from FY 2021). Net loss: RM50.4m (down 367% from profit in FY 2021). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 28% per year, which means it is performing significantly worse than earnings.Reported Earnings • Apr 21Third quarter 2022 earnings released: RM0.32 loss per share (vs RM0.028 profit in 3Q 2021)Third quarter 2022 results: RM0.32 loss per share (down from RM0.028 profit in 3Q 2021). Revenue: RM273.8m (down 5.3% from 3Q 2021). Net loss: RM57.7m (down RM62.6m from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to RM1.53, the stock trades at a trailing P/E ratio of 11.4x. Average trailing P/E is 13x in the Chemicals industry in Malaysia. Total returns to shareholders of 138% over the past three years.Upcoming Dividend • Mar 01Inaugural dividend of RM0.39 per shareEligible shareholders must have bought the stock before 08 March 2022. Payment date: 23 March 2022. The company is not currently making a profit and is not cash flow positive. The company last paid an ordinary dividend in September 2019. The average dividend yield among industry peers is 4.3%.공고 • Jan 27Ancom Berhad (KLSE:ANCOM) completed the acquisition of remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX).Ancom Berhad (KLSE:ANCOM) entered into an agreement to acquire remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) for MYR 96.7 million on July 29, 2021. Ancom Berhad (KLSE:ANCOM) submitted a formal offer to acquire remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) for MYR 96.7 million on April 28, 2021. Out of total consideration, MYR 50 million will be paid in cash and MYR 46.7 million via the issuance of 31,129,508 new Ancom Shares at an issue price of MYR 1.50 per Ancom Share. Post completion of the Proposed Acquisition, Ancom will continue to hold 50.27% equity interest in Nylex. The Cash Consideration will be funded through a bank borrowings. Out of total consideration, Nylex to distribute an amount equivalent to MYR 164.29 million to its shareholders and retain MYR 15 million for its working capital and general corporate purposes. The Proposed Acquisition is subject to approval of the shareholders of Ancom at an extraordinary general meeting to be convened; approval of Bursa Securities for the listing and quotation of the Consideration Shares on the Main Market of Bursa Securities; approval of the shareholders of Nylex at an EGM to be convened; regulatory approvals; approval/consent from financiers/creditors of Ancom, Rhodemark and/or the Nylex Group upon the terms and subject to the conditions of the Sale of Business Agreement, where required; grant of an order of the High Court of Malaya pursuant to Section 116 of the CA 2016 and other closing conditions. As of June 28, 2021, board of Nylex (Malaysia) Berhad accepted the offer. As of August 18, 2021, on behalf of the Ancom Board, Maybank IB wishes to announce that the additional listing application in relation to the Consideration Shares to be issued pursuant to the Proposed Acquisition has been submitted to Bursa Securities. As of September 23, 2021 on behalf of the Ancom Board, Maybank IB wishes to announce that Bursa Securities had via its letter dated September 23, 2021, approved the listing of and quotation for 31,129,508 new ordinary shares in Ancom to be issued pursuant to the Proposed Acquisition, subject to, among others conditions. The Proposal Letter shall remain valid for acceptance by the Nylex Board until 5.00 p.m. on June 28, 2021, unless extended by mutual agreement in writing and the parties are to negotiate and finalise the terms and conditions of the Sale of Business Agreement and enter into the Sale of Business Agreement within 60 days from the date of acceptance of the Proposal Letter (or such other period as the parties may agree in writing). The completion of the Proposed Acquisition shall take place at the office of Nylex on or before the date falling 90 days after the Sale of Business Agreement becomes unconditional or is deemed to have become unconditional. As of January 12, 2022, Maybank IB wishes to announce that Nylex has today, obtained the order of the High Court of Malaya confirming the special resolution passed by the shareholders of Nylex on October 26, 2021 approving the reduction of the issued share capital of Nylex and the transaction. The transaction has become unconditional. KAF Investment Bank Berhad acted as financial advisor to Audit Committee of Ancom. Maybank Investment Bank Berhad acted as financial advisor to Ancom. Ancom Berhad (KLSE:ANCOM) completed the acquisition of remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) on January 26, 2022.Reported Earnings • Jan 19Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: EPS: RM0.043 (up from RM0.026 in 2Q 2021). Revenue: RM385.4m (up 46% from 2Q 2021). Net income: RM7.73m (up 72% from 2Q 2021). Profit margin: 2.0% (up from 1.7% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 31% per year and the company’s share price has also increased by 31% per year.Valuation Update With 7 Day Price Move • Dec 30Investor sentiment improved over the past weekAfter last week's 15% share price gain to RM1.44, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 16x in the Chemicals industry in Malaysia. Total returns to shareholders of 127% over the past three years.분석 기사 • Dec 27Is Nylex (Malaysia) Berhad (KLSE:NYLEX) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...공고 • Dec 10Nylex (Malaysia) Berhad to Be Deleted from Other OTCNylex (Malaysia) Berhad's Ordinary Shares will be deleted from other OTC effective from December 10, 2021 due to Inactive Security.Valuation Update With 7 Day Price Move • Oct 25Investor sentiment improved over the past weekAfter last week's 20% share price gain to RM1.42, the stock trades at a trailing P/E ratio of 13.5x. Average trailing P/E is 17x in the Chemicals industry in Malaysia. Total returns to shareholders of 134% over the past three years.Reported Earnings • Oct 04Full year 2021 earnings released: EPS RM0.11 (vs RM0.13 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.15b (up 1.4% from FY 2020). Net income: RM18.9m (up RM42.1m from FY 2020). Profit margin: 1.6% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance.분석 기사 • Sep 21Nylex (Malaysia) Berhad (KLSE:NYLEX) Seems To Use Debt Quite SensiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Jul 31Full year 2021 earnings released: EPS RM0.11 (vs RM0.13 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.15b (up 1.4% from FY 2020). Net income: RM19.3m (up RM42.5m from FY 2020). Profit margin: 1.7% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.분석 기사 • May 06We Think Nylex (Malaysia) Berhad (KLSE:NYLEX) Is Taking Some Risk With Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Apr 29Third quarter 2021 earnings released: EPS RM0.028 (vs RM0.021 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: RM289.1m (up 5.0% from 3Q 2020). Net income: RM4.94m (up RM8.62m from 3Q 2020). Profit margin: 1.7% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 121 percentage points per year, which is a significant difference in performance.Is New 90 Day High Low • Mar 10New 90-day high: RM0.69The company is up 12% from its price of RM0.62 on 10 December 2020. The Malaysian market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period.Reported Earnings • Jan 27Second quarter 2021 earnings released: EPS RM0.026 (vs RM0.002 in 2Q 2020)The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: RM263.4m (down 17% from 2Q 2020). Net income: RM4.49m (up RM4.22m from 2Q 2020). Profit margin: 1.7% (up from 0.1% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 109 percentage points per year, which is a significant difference in performance.분석 기사 • Jan 15We Think Nylex (Malaysia) Berhad (KLSE:NYLEX) Has A Fair Chunk Of DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Is New 90 Day High Low • Dec 17New 90-day high: RM0.67The company is up 8.0% from its price of RM0.61 on 18 September 2020. The Malaysian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 33% over the same period.분석 기사 • Nov 23Here's What We Learned About The CEO Pay At Nylex (Malaysia) Berhad (KLSE:NYLEX)This article will reflect on the compensation paid to Ka Wei Siew who has served as CEO of Nylex (Malaysia) Berhad...Is New 90 Day High Low • Nov 02New 90-day low: RM0.54The company is down 24% from its price of RM0.70 on 04 August 2020. The Malaysian market is down 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.Reported Earnings • Oct 28First quarter earnings releasedOver the last 12 months the company has reported total losses of RM23.6m, with losses widening by 213% from the prior year. Total revenue was RM1.07b over the last 12 months, down 27% from the prior year.Reported Earnings • Oct 01Full year earnings released - RM0.13 loss per shareOver the last 12 months the company has reported total losses of RM23.2m, with losses widening by RM19.8m from the prior year. Total revenue was RM1.14b over the last 12 months, down 27% from the prior year.Is New 90 Day High Low • Sep 29New 90-day low: RM0.56The company is down 15% from its price of RM0.65 on 01 July 2020. The Malaysian market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 4.0% over the same period.매출 및 비용 세부 내역Nylex (Malaysia) Berhad가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KLSE:NYLEX 매출, 비용 및 순이익 (MYR Millions)날짜매출순이익일반관리비연구개발비29 Feb 240-23030 Nov 230-22031 Aug 230-22031 May 230-22028 Feb 23-93448-62030 Nov 22-660-10-45031 Aug 22-275-1-16031 May 220-11028 Feb 22136-581030 Nov 2115147031 Aug 21291-2031 May 210-11028 Feb 211,029-1187030 Nov 201,015-1990031 Aug 201,068-2496031 May 201,136-2399029 Feb 201,286-496030 Nov 191,336-798031 Aug 191,455-896031 May 191,560-3100028 Feb 191,6052109030 Nov 181,62414107031 Aug 181,55321108031 May 181,44619105028 Feb 181,40220104030 Nov 171,42722104031 Aug 171,37822103031 May 171,33720103028 Feb 171,2482097030 Nov 161,1351493031 Aug 161,1481090031 May 161,1971188029 Feb 161,231790030 Nov 151,245587031 Aug 151,237686031 May 151,273784028 Feb 151,325473030 Nov 141,380875031 Aug 141,508977031 May 141,566882028 Feb 141,6311193030 Nov 131,706998031 Aug 131,704899031 May 131,7298970양질의 수익: NYLEX 은(는) 현재 수익성이 없습니다.이익 마진 증가: NYLEX는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: NYLEX는 수익성이 없지만 지난 5년 동안 연평균 23.1%의 속도로 손실을 줄였습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 NYLEX의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: NYLEX은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(3.3%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: NYLEX는 현재 수익성이 없으므로 자본 수익률이 음수(-11.89%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/05/05 07:53종가2024/02/06 00:00수익2024/02/29연간 수익2023/05/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Nylex (Malaysia) Berhad는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Oct 04Full year 2022 earnings released: RM0.007 loss per share (vs RM0.004 loss in FY 2021)Full year 2022 results: RM0.007 loss per share (further deteriorated from RM0.004 loss in FY 2021). Net loss: RM1.26m (loss widened 70% from FY 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings.
Reported Earnings • Jul 20Full year 2022 earnings released: RM0.28 loss per share (vs RM0.11 profit in FY 2021)Full year 2022 results: RM0.28 loss per share (down from RM0.11 profit in FY 2021). Revenue: RM934.1m (down 19% from FY 2021). Net loss: RM50.4m (down 367% from profit in FY 2021). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 28% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Apr 21Third quarter 2022 earnings released: RM0.32 loss per share (vs RM0.028 profit in 3Q 2021)Third quarter 2022 results: RM0.32 loss per share (down from RM0.028 profit in 3Q 2021). Revenue: RM273.8m (down 5.3% from 3Q 2021). Net loss: RM57.7m (down RM62.6m from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.
Reported Earnings • Jan 19Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: EPS: RM0.043 (up from RM0.026 in 2Q 2021). Revenue: RM385.4m (up 46% from 2Q 2021). Net income: RM7.73m (up 72% from 2Q 2021). Profit margin: 2.0% (up from 1.7% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 31% per year and the company’s share price has also increased by 31% per year.
Reported Earnings • Oct 04Full year 2021 earnings released: EPS RM0.11 (vs RM0.13 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.15b (up 1.4% from FY 2020). Net income: RM18.9m (up RM42.1m from FY 2020). Profit margin: 1.6% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance.
Reported Earnings • Jul 31Full year 2021 earnings released: EPS RM0.11 (vs RM0.13 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.15b (up 1.4% from FY 2020). Net income: RM19.3m (up RM42.5m from FY 2020). Profit margin: 1.7% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.
공고 • Mar 08Nylex to Delist from Bursa Malaysia on March 11Nylex (Malaysia) Berhad is set to be delisted from Bursa Malaysia on March 11, following the company’s failure to submit its regularisation plan on time. In a filing with Bursa Malaysia on March 6, 2025, the bourse regulator said it has dismissed the company's appeal for a further extension of six months until July 26, 2025 to submit its regularisation plan to the relevant authorities for approval. As such, Bursa Malaysia said the company would be delisted from Bursa Malaysia after two market days from March 6, that is on March 11, 2025. Upon the de-listing of the company, the company will continue to exist but as an unlisted entity. The company can still continue its operations and businesses and proceed with its corporate restructuring.
공고 • Sep 27Nylex (Malaysia) Berhad, Annual General Meeting, Oct 29, 2024Nylex (Malaysia) Berhad, Annual General Meeting, Oct 29, 2024, at 09:30 Singapore Standard Time. Location: no. 2a, jalan 13/2, seksyen 13, 46200 petaling jaya, selangor darul ehsan, Malaysia
공고 • Jan 31Nylex (Malaysia) Berhad Provides Update Related to Suspension & Delisting of SecuritiesRefer to the Nylex (Malaysia) Berhad’s announcements dated 27 January 2022 and 28 January 2022 in relation to the First Announcement and the announcements made on 16 August 2023, 23 August 2023, 13 October 2023 and 26 January 2024. Unless otherwise stated, all abbreviations and definitions used herein shall have the same meanings as those used in the said announcements. The Board announced that Bursa Securities had via its letter dated 29 January 2024 informed the Company that Bursa Securities has noted that: a) Nylex had failed to submit the proposed regularisation plan to the relevant authorities for approval within the extended timeframe of 26 January 2024 as granted by the Listing Committee via its letter dated 13 October 2023 (“LC Decision Letter”); and b) the Company has on 26 January 2024, appealed/applied for a further extension of time ("Appeal"). In the circumstances and pursuant to paragraph 8.03A(3) of the Listing Requirements and the LC Decision Letter, (i) the trading in the securities of Nylex will be suspended with effect from 7 February 2024 ("Suspension Date") even though the decision on the Appeal is still pending. (ii) However, the de-listing of the securities of the Company upon the expiry of 2 market days from the Suspension Date will be deferred pending the decision on the Appeal by Bursa Securities.
New Risk • Jan 30New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RM40.5m (US$8.55m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (RM211k revenue, or US$45k). Market cap is less than US$10m (RM40.5m market cap, or US$8.55m). Minor Risk Share price has been volatile over the past 3 months (11% average weekly change).
공고 • Sep 27Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2023Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2023, at 09:30 Singapore Standard Time. Location: No. 2A, Jalan 13/2, Seksyen 13,46200 Petaling Jaya Selangor Malaysia Agenda: To receive the Audited Financial Statements for the financial year ended 31 May 2023 together with the Reports of the Directors and the Auditors; To re-elect as Director, Datin Joanne Marie Lopez who is retiring pursuant to Clause 130 of the Company's Constitution; to approve the payment of Non-Executive Directors' fees for the financial year ended 31 May 2023; to approve the payment of Non-Executive Directors' fees for the financial year ending 31 May 2024, to be paid quarterly in arrears; to re-appoint Messrs BDO PLT as Auditors of the Company and to authorise the Directors to fix their remuneration and to consider other business matters.
New Risk • Aug 18New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: RM44.9m (US$9.66m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 12% per year over the past 5 years. Revenue is less than US$1m (RM211k revenue, or US$45k). Market cap is less than US$10m (RM44.9m market cap, or US$9.66m).
공고 • Jun 29+ 9 more updatesNylex (Malaysia) Berhad Announces Redesignation of Edmond Cheah Swee Leng from Chairman of Nomination and Remuneration Committee to Non Independent and Non Executive Member of Nomination and Remuneration CommitteeNylex (Malaysia) Berhad announced redesignation of EDMOND CHEAH SWEE LENG from Chairman of Nomination and Remuneration Committee to Non Independent and Non Executive Member of Nomination and Remuneration Committee. Age 68, Date of change 28 June 2023. Composition of Nomination and Remuneration Committee(Name and Directorate of members after change). Chairman: Datin Joanne Marie Lopez (Independent Non Executive Director) Members: Datuk Anuar Bin Ahmad (Independent Non Executive Director) Edmond Cheah Swee Leng (Non ndependent Non Executive Director).
Board Change • Jan 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 5 highly experienced directors. Independent Non-Executive Director See Yan Lin was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Oct 04Full year 2022 earnings released: RM0.007 loss per share (vs RM0.004 loss in FY 2021)Full year 2022 results: RM0.007 loss per share (further deteriorated from RM0.004 loss in FY 2021). Net loss: RM1.26m (loss widened 70% from FY 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings.
공고 • Sep 29Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2022Nylex (Malaysia) Berhad, Annual General Meeting, Oct 27, 2022, at 09:30 Singapore Standard Time. Location: No. 2a, Jalan 13/2, Seksyen 13, 46200 Petaling Jaya Darul Ehsan Selangor Malaysia Agenda: To receive the audited financial statements for the financial year ended 31 May 2022 together with the Reports of the Directors and the Auditors thereon; to re-elect the directors who are retiring by rotation; to approve the payment of Non-Executive Directors' fees for the financial year ended 31 May 2022; to approve the payment of Directors' benefits (excluding Non-Executive Directors' fees) for the Non-Executive Directors from the date of the forthcoming AGM until the next annual general meeting of the Company; to re-appoint Messrs BDO PLT as Auditors of the Company and to authorize the Directors to fix their remuneration; to discuss proposed renewal authority for share buy-back mandate; and to discuss other matters.
Reported Earnings • Jul 20Full year 2022 earnings released: RM0.28 loss per share (vs RM0.11 profit in FY 2021)Full year 2022 results: RM0.28 loss per share (down from RM0.11 profit in FY 2021). Revenue: RM934.1m (down 19% from FY 2021). Net loss: RM50.4m (down 367% from profit in FY 2021). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 28% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Apr 21Third quarter 2022 earnings released: RM0.32 loss per share (vs RM0.028 profit in 3Q 2021)Third quarter 2022 results: RM0.32 loss per share (down from RM0.028 profit in 3Q 2021). Revenue: RM273.8m (down 5.3% from 3Q 2021). Net loss: RM57.7m (down RM62.6m from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Mar 07Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to RM1.53, the stock trades at a trailing P/E ratio of 11.4x. Average trailing P/E is 13x in the Chemicals industry in Malaysia. Total returns to shareholders of 138% over the past three years.
Upcoming Dividend • Mar 01Inaugural dividend of RM0.39 per shareEligible shareholders must have bought the stock before 08 March 2022. Payment date: 23 March 2022. The company is not currently making a profit and is not cash flow positive. The company last paid an ordinary dividend in September 2019. The average dividend yield among industry peers is 4.3%.
공고 • Jan 27Ancom Berhad (KLSE:ANCOM) completed the acquisition of remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX).Ancom Berhad (KLSE:ANCOM) entered into an agreement to acquire remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) for MYR 96.7 million on July 29, 2021. Ancom Berhad (KLSE:ANCOM) submitted a formal offer to acquire remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) for MYR 96.7 million on April 28, 2021. Out of total consideration, MYR 50 million will be paid in cash and MYR 46.7 million via the issuance of 31,129,508 new Ancom Shares at an issue price of MYR 1.50 per Ancom Share. Post completion of the Proposed Acquisition, Ancom will continue to hold 50.27% equity interest in Nylex. The Cash Consideration will be funded through a bank borrowings. Out of total consideration, Nylex to distribute an amount equivalent to MYR 164.29 million to its shareholders and retain MYR 15 million for its working capital and general corporate purposes. The Proposed Acquisition is subject to approval of the shareholders of Ancom at an extraordinary general meeting to be convened; approval of Bursa Securities for the listing and quotation of the Consideration Shares on the Main Market of Bursa Securities; approval of the shareholders of Nylex at an EGM to be convened; regulatory approvals; approval/consent from financiers/creditors of Ancom, Rhodemark and/or the Nylex Group upon the terms and subject to the conditions of the Sale of Business Agreement, where required; grant of an order of the High Court of Malaya pursuant to Section 116 of the CA 2016 and other closing conditions. As of June 28, 2021, board of Nylex (Malaysia) Berhad accepted the offer. As of August 18, 2021, on behalf of the Ancom Board, Maybank IB wishes to announce that the additional listing application in relation to the Consideration Shares to be issued pursuant to the Proposed Acquisition has been submitted to Bursa Securities. As of September 23, 2021 on behalf of the Ancom Board, Maybank IB wishes to announce that Bursa Securities had via its letter dated September 23, 2021, approved the listing of and quotation for 31,129,508 new ordinary shares in Ancom to be issued pursuant to the Proposed Acquisition, subject to, among others conditions. The Proposal Letter shall remain valid for acceptance by the Nylex Board until 5.00 p.m. on June 28, 2021, unless extended by mutual agreement in writing and the parties are to negotiate and finalise the terms and conditions of the Sale of Business Agreement and enter into the Sale of Business Agreement within 60 days from the date of acceptance of the Proposal Letter (or such other period as the parties may agree in writing). The completion of the Proposed Acquisition shall take place at the office of Nylex on or before the date falling 90 days after the Sale of Business Agreement becomes unconditional or is deemed to have become unconditional. As of January 12, 2022, Maybank IB wishes to announce that Nylex has today, obtained the order of the High Court of Malaya confirming the special resolution passed by the shareholders of Nylex on October 26, 2021 approving the reduction of the issued share capital of Nylex and the transaction. The transaction has become unconditional. KAF Investment Bank Berhad acted as financial advisor to Audit Committee of Ancom. Maybank Investment Bank Berhad acted as financial advisor to Ancom. Ancom Berhad (KLSE:ANCOM) completed the acquisition of remaining 49.73% of Assets and liabilities of Nylex (Malaysia) Berhad (KLSE:NYLEX) on January 26, 2022.
Reported Earnings • Jan 19Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: EPS: RM0.043 (up from RM0.026 in 2Q 2021). Revenue: RM385.4m (up 46% from 2Q 2021). Net income: RM7.73m (up 72% from 2Q 2021). Profit margin: 2.0% (up from 1.7% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 31% per year and the company’s share price has also increased by 31% per year.
Valuation Update With 7 Day Price Move • Dec 30Investor sentiment improved over the past weekAfter last week's 15% share price gain to RM1.44, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 16x in the Chemicals industry in Malaysia. Total returns to shareholders of 127% over the past three years.
분석 기사 • Dec 27Is Nylex (Malaysia) Berhad (KLSE:NYLEX) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
공고 • Dec 10Nylex (Malaysia) Berhad to Be Deleted from Other OTCNylex (Malaysia) Berhad's Ordinary Shares will be deleted from other OTC effective from December 10, 2021 due to Inactive Security.
Valuation Update With 7 Day Price Move • Oct 25Investor sentiment improved over the past weekAfter last week's 20% share price gain to RM1.42, the stock trades at a trailing P/E ratio of 13.5x. Average trailing P/E is 17x in the Chemicals industry in Malaysia. Total returns to shareholders of 134% over the past three years.
Reported Earnings • Oct 04Full year 2021 earnings released: EPS RM0.11 (vs RM0.13 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.15b (up 1.4% from FY 2020). Net income: RM18.9m (up RM42.1m from FY 2020). Profit margin: 1.6% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance.
분석 기사 • Sep 21Nylex (Malaysia) Berhad (KLSE:NYLEX) Seems To Use Debt Quite SensiblyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Jul 31Full year 2021 earnings released: EPS RM0.11 (vs RM0.13 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: RM1.15b (up 1.4% from FY 2020). Net income: RM19.3m (up RM42.5m from FY 2020). Profit margin: 1.7% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance.
분석 기사 • May 06We Think Nylex (Malaysia) Berhad (KLSE:NYLEX) Is Taking Some Risk With Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Apr 29Third quarter 2021 earnings released: EPS RM0.028 (vs RM0.021 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: RM289.1m (up 5.0% from 3Q 2020). Net income: RM4.94m (up RM8.62m from 3Q 2020). Profit margin: 1.7% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 121 percentage points per year, which is a significant difference in performance.
Is New 90 Day High Low • Mar 10New 90-day high: RM0.69The company is up 12% from its price of RM0.62 on 10 December 2020. The Malaysian market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period.
Reported Earnings • Jan 27Second quarter 2021 earnings released: EPS RM0.026 (vs RM0.002 in 2Q 2020)The company reported a decent second quarter result with improved earnings and profit margins, although revenues were weaker. Second quarter 2021 results: Revenue: RM263.4m (down 17% from 2Q 2020). Net income: RM4.49m (up RM4.22m from 2Q 2020). Profit margin: 1.7% (up from 0.1% in 2Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 109 percentage points per year, which is a significant difference in performance.
분석 기사 • Jan 15We Think Nylex (Malaysia) Berhad (KLSE:NYLEX) Has A Fair Chunk Of DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Is New 90 Day High Low • Dec 17New 90-day high: RM0.67The company is up 8.0% from its price of RM0.61 on 18 September 2020. The Malaysian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 33% over the same period.
분석 기사 • Nov 23Here's What We Learned About The CEO Pay At Nylex (Malaysia) Berhad (KLSE:NYLEX)This article will reflect on the compensation paid to Ka Wei Siew who has served as CEO of Nylex (Malaysia) Berhad...
Is New 90 Day High Low • Nov 02New 90-day low: RM0.54The company is down 24% from its price of RM0.70 on 04 August 2020. The Malaysian market is down 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.
Reported Earnings • Oct 28First quarter earnings releasedOver the last 12 months the company has reported total losses of RM23.6m, with losses widening by 213% from the prior year. Total revenue was RM1.07b over the last 12 months, down 27% from the prior year.
Reported Earnings • Oct 01Full year earnings released - RM0.13 loss per shareOver the last 12 months the company has reported total losses of RM23.2m, with losses widening by RM19.8m from the prior year. Total revenue was RM1.14b over the last 12 months, down 27% from the prior year.
Is New 90 Day High Low • Sep 29New 90-day low: RM0.56The company is down 15% from its price of RM0.65 on 01 July 2020. The Malaysian market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is down 4.0% over the same period.